Impact (REF3a/b)

Impact template (REF3a)

Download template (167K)

All impact case studies

Download all case studies (4.4MB)

Individual case studies

A new pharmacological approach for treating ADHD (365K)

Acid-sensing ion channels (ASICs), pain mechanisms and treatment (244K)

Antibody sequence and structure analysis assists biologic drug design (125K)

Application of advanced analytical methods for damage assessment of cultural artefacts in museums and historic buildings (252K)

BioVex: UCL spin-out company develops viral cancer therapy to phase III trial and is sold for $1bn (302K)

CATH structural classification of proteins aids drug discovery in the pharmaceutical industry (129K)

Combinatorial protein domain hunting to facilitate drug discovery (249K)

Critical evaluation of evidence in medicine and epidemiology: impacts on higher education, the NHS and public understanding of science (282K)

Enhancing public awareness and engagement with evolutionary cell biology (294K)

Fungus research: impacts on pest control, heritage conservation and public awareness of science (335K)

Healing chronic wounds with Nexagon (258K)

Identification and cloning of the P2Y receptor class leads to new therapies targeting purinergic signalling (316K)

Improving the diagnosis and understanding of Batten Disease (200K)

Pain relief for hospitalised infants (339K)

Sodium channels, pain and analgesia (255K)

The DichroWeb Analysis Server and Protein Circular Dichroism Data Bank: analysis tools for structural biology (255K)

The neurobiological basis of fetal awareness – impact upon recommended obstetric practice. (306K)

Trimethylaminuria is a genetic disorder (364K)

Use of the structure of serum amyloid P, a modulator of amyloid formation, for drug discovery and development (241K)